Cardiotoxicity can present itself in both acute and chronic forms. Acute cardiotoxicity may occur during or immediately after treatment, characterized by symptoms such as arrhythmias or a sudden drop in heart function. Chronic cardiotoxicity might manifest years after the completion of cancer therapy, leading to long-term issues like cardiomyopathy and congestive heart failure. Monitoring for signs of cardiotoxicity is crucial for early detection and intervention.
